Product Portfolio

Biopharmaceuticals are regarded as one of the most exciting areas of modern medicines. In contrast to chemically synthesized pharmaceuticals, biopharmaceuticals are “grown” and “harvested” though a process of fermentation and subsequent purification steps. Through the formulation, additional properties may be achieved to improve delivery and bioavailability. Many biopharmaceuticals are being used in clinical practice to treat a variety of medical conditions, including diabetes, leukemia and hemophilia.  

"Biopartners is uncompromising in its development of Biopharmaceuticals that are both safe and efficient."

Biopartners has a broad and advanced product pipeline of both innovative formulations and novel delivery systems of first-generation biopharmaceuticals and biosimilars. The current portfolio comprises five key recombinant biopharmaceutical products and one chemically derived product candidate in various stages of development.

Product Pipeline